FDA Approves Nanosphere Verigene System

The FDA has granted Nanosphere Inc. of Northbrook, Ill., approval for the Verigene system, a molecular diagnostics platform that utilizes gold nanoparticle technology to detect nucleic acids in a multiplex format. The company also has received FDA approval for its test for warfarin sensitivity, which uses the Verigene system to test for variations in two genes to determine the appropriate dosing levels for individual patients.





LATEST NEWS

• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024